475830 fundamentals
An in-depth look to ORUM THERAPEUTICS, INC. operating, investing, and financing activities
475830 free cash flow for Q1 25 is -7.39 B KRW. For 2024, 475830 free cash flow was -12.55 B KRW and operating cash flow was -11.28 B KRW.
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: KRW
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM